BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 26681028)

  • 1. Expression and prognostic influence of NF-κB and EGFR in esophageal cancer.
    Zhang YQ; Zhang JJ; Song HJ; Li DW
    Genet Mol Res; 2015 Dec; 14(4):16819-26. PubMed ID: 26681028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma.
    Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R
    Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma].
    Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship of cysteine-rich protein 61 and NF-kappaB expression with metastasis and prognosis of gastric carcinoma].
    Ma HF; Zhao ZS
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):815-21. PubMed ID: 19159527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR inhibits the invasion and growth of esophageal cancer cells by inhibiting the expression of NF-κB.
    Li W; Wang C; Peng X; Zhang H; Huang H; Liu H
    Cell Biol Int; 2018 Dec; 42(12):1680-1687. PubMed ID: 30358020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.
    Izzo JG; Malhotra U; Wu TT; Luthra R; Correa AM; Swisher SG; Hofstetter W; Chao KS; Hung MC; Ajani JA
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1200-5. PubMed ID: 17548685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
    Izzo JG; Malhotra U; Wu TT; Ensor J; Luthra R; Lee JH; Swisher SG; Liao Z; Chao KS; Hittelman WN; Aggarwal BB; Ajani JA
    J Clin Oncol; 2006 Feb; 24(5):748-54. PubMed ID: 16401681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy.
    Zhou S; Ye W; Shao Q; Qi Y; Zhang M; Liang J
    World J Surg Oncol; 2013 Nov; 11():288. PubMed ID: 24188482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
    Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
    Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
    Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
    Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of molecular biomarkers in esophageal carcinoma in different nationalities patients in Xinjiang.
    Zhang L; Sun J; Zhang JQ; Yang M; Bai G; Ma XL
    Genet Mol Res; 2014 Jul; 13(3):5413-25. PubMed ID: 25078598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer.
    Yousif NG; Al-Amran FG; Hadi N; Lee J; Adrienne J
    Cytokine; 2013 Jan; 61(1):223-7. PubMed ID: 23107826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship and clinical significance of KiSS-1, nuclear factor kappa B (NF-kappaB), p50, and matrix metalloproteinase 9 expression in breast cancer].
    Yi X; Li CY; Zhang SH; Wang XH; Li ZQ; Yang F
    Zhonghua Bing Li Xue Za Zhi; 2008 Apr; 37(4):238-42. PubMed ID: 18844032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
    Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
    Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.
    Sasaki N; Morisaki T; Hashizume K; Yao T; Tsuneyoshi M; Noshiro H; Nakamura K; Yamanaka T; Uchiyama A; Tanaka M; Katano M
    Clin Cancer Res; 2001 Dec; 7(12):4136-42. PubMed ID: 11751513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.